Skip to main content

RHUMBLINE ADVISERS

Position in RPRX — Royalty Pharma plc

CIK 1115418 BOSTON, MA

Position in RPRX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$22,032,525
+$4,051,517 QoQ
Shares Held
459,298
-1.3% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 44% Shared 0% None 56%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. RPRX ranks #14 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RPRX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $22,032,525 459,298
2025-12-31 $17,981,008 465,347
2025-09-30 $15,845,765 449,143
2025-06-30 $16,114,057 447,240
2025-03-31 $14,007,379 449,964
2024-12-31 $11,585,315 454,148
2024-09-30 $12,942,957 457,510
2024-06-30 $11,789,525 447,081
2024-03-31 $13,916,931 458,246
2023-12-31 $12,802,186 455,756
2023-09-30 $12,519,654 461,299
2023-06-30 $14,611,244 475,317
2023-03-31 $15,071,565 418,306
2022-12-31 $16,248,331 411,142
2022-09-30 $15,519,645 386,253
2022-06-30 $14,494,467 344,778
2022-03-31 $10,815,568 277,607
2021-12-31 $11,264,120 282,663
2021-09-30 $9,848,222 272,502
2021-06-30 $11,856,603 289,256
2021-03-31 $12,946,546 296,803
2020-12-31 $4,872,918 97,361
2020-09-30 $3,229,671 76,769